ATE167187T1 - Chinuclidinestern, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen - Google Patents

Chinuclidinestern, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen

Info

Publication number
ATE167187T1
ATE167187T1 AT92918526T AT92918526T ATE167187T1 AT E167187 T1 ATE167187 T1 AT E167187T1 AT 92918526 T AT92918526 T AT 92918526T AT 92918526 T AT92918526 T AT 92918526T AT E167187 T1 ATE167187 T1 AT E167187T1
Authority
AT
Austria
Prior art keywords
pct
processes
production
alkyl
image
Prior art date
Application number
AT92918526T
Other languages
English (en)
Inventor
Peter Edward Cross
Alan Stobie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE167187T1 publication Critical patent/ATE167187T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT92918526T 1991-09-14 1992-09-03 Chinuclidinestern, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen ATE167187T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919119705A GB9119705D0 (en) 1991-09-14 1991-09-14 Therapeutic compounds

Publications (1)

Publication Number Publication Date
ATE167187T1 true ATE167187T1 (de) 1998-06-15

Family

ID=10701448

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92918526T ATE167187T1 (de) 1991-09-14 1992-09-03 Chinuclidinestern, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen

Country Status (31)

Country Link
US (1) US5543419A (de)
EP (1) EP0603229B1 (de)
JP (2) JP2672030B2 (de)
KR (1) KR0135784B1 (de)
CN (1) CN1037269C (de)
AT (1) ATE167187T1 (de)
AU (1) AU659487B2 (de)
BR (1) BR9206499A (de)
CA (1) CA2116356C (de)
CZ (1) CZ281752B6 (de)
DE (1) DE69225897T2 (de)
DK (1) DK0603229T3 (de)
EG (1) EG20072A (de)
ES (1) ES2116343T3 (de)
FI (1) FI114707B (de)
GB (1) GB9119705D0 (de)
GR (1) GR3027667T3 (de)
HU (1) HU220594B1 (de)
IL (1) IL103078A (de)
MX (1) MX9205221A (de)
MY (1) MY108602A (de)
NO (1) NO305397B1 (de)
NZ (1) NZ244324A (de)
PL (1) PL170627B1 (de)
PT (1) PT100863B (de)
RU (1) RU2117669C1 (de)
SG (1) SG50414A1 (de)
TW (1) TW251285B (de)
UA (1) UA42686C2 (de)
WO (1) WO1993006098A1 (de)
ZA (1) ZA926939B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT785198E (pt) * 1996-01-19 2000-11-30 Lonza Ag Processo para a producao de 3-quinuclidinol opticamente activo.
CZ54498A3 (cs) * 1997-03-07 1998-11-11 Lonza Ag Katalyzátorová směs na bázi amorfního částečně dehydratovaného hydroxidu zirkoničitého a způsob její výroby a použití
DE69833665T2 (de) * 1997-08-08 2006-11-09 Duke University Zusammensetzungen zur vereinfachung von chirurgischen verfahren
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
HUP0303529A3 (en) * 2000-12-22 2008-03-28 Almirall Ag New quinuclidine carbamate derivatives, process for their preparation and pharmaceutical compositions containing them and their use
CN1250545C (zh) 2000-12-28 2006-04-12 阿尔米雷尔普罗迪斯制药有限公司 新的奎宁环衍生物类及含有这类衍生物的药物组合物
GB0424284D0 (en) * 2004-11-02 2004-12-01 Novartis Ag Organic compounds
DE102004057995A1 (de) * 2004-12-01 2006-06-08 Wacker Chemie Ag Verfahren zur Herstellung von α,α-Dialkyl-α-Hydroxymethyl-Carbonsäurederivaten
ES2298049B1 (es) * 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
EP2114972A2 (de) * 2006-12-13 2009-11-11 Gilead Sciences, Inc. Monophosphate als gemeinsame prodrugs für muskarinrezeptorantagonisten und beta-agonisten für die behandlung von copd und chronischer bronchitis
EP2100599A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100598A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2510928A1 (de) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843074A (en) * 1988-05-17 1989-06-27 Marion Laboratories, Inc. 1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts
GB8923590D0 (en) * 1989-10-19 1989-12-06 Pfizer Ltd Antimuscarinic bronchodilators

Also Published As

Publication number Publication date
JPH06510991A (ja) 1994-12-08
FI114707B (fi) 2004-12-15
EG20072A (en) 1999-06-30
CA2116356C (en) 1998-03-31
CZ281752B6 (cs) 1997-01-15
EP0603229B1 (de) 1998-06-10
JPH09315970A (ja) 1997-12-09
KR0135784B1 (ko) 1998-04-23
NZ244324A (en) 1993-12-23
MX9205221A (es) 1993-03-01
GR3027667T3 (en) 1998-11-30
JP2672030B2 (ja) 1997-11-05
HU220594B1 (hu) 2002-03-28
JP2955533B2 (ja) 1999-10-04
FI941170A0 (fi) 1994-03-11
WO1993006098A1 (en) 1993-04-01
BR9206499A (pt) 1995-11-21
MY108602A (en) 1996-10-31
CN1070911A (zh) 1993-04-14
IL103078A0 (en) 1993-02-21
UA42686C2 (uk) 2001-11-15
DE69225897T2 (de) 1998-10-15
CN1037269C (zh) 1998-02-04
NO940905D0 (no) 1994-03-14
IL103078A (en) 1996-07-23
GB9119705D0 (en) 1991-10-30
NO305397B1 (no) 1999-05-25
AU659487B2 (en) 1995-05-18
DK0603229T3 (da) 1998-10-12
AU2482392A (en) 1993-04-27
PT100863A (pt) 1993-10-29
EP0603229A1 (de) 1994-06-29
ZA926939B (en) 1994-03-11
ES2116343T3 (es) 1998-07-16
CA2116356A1 (en) 1993-04-01
HU9400729D0 (en) 1994-06-28
NO940905L (no) 1994-03-14
US5543419A (en) 1996-08-06
RU2117669C1 (ru) 1998-08-20
CZ395392A3 (en) 1994-07-13
PL170627B1 (en) 1997-01-31
DE69225897D1 (de) 1998-07-16
PT100863B (pt) 1999-07-30
HUT66772A (en) 1994-12-28
FI941170L (fi) 1994-03-11
SG50414A1 (en) 1998-07-20
TW251285B (de) 1995-07-11

Similar Documents

Publication Publication Date Title
DE69225897D1 (de) Chinuclidinestern, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
AU677852B2 (en) Acetamide derivatives and their use for modifying feeding behavior modifiers
AU550774B2 (en) 1-aryl-2-aminomethyl cyclopropane carboxylates
ATE128458T1 (de) Naphtylalkylamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
AU7503087A (en) Amide derivatives
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GR3034769T3 (en) Triazole antifungal agents.
ATE192143T1 (de) Substituierte 2,2-dimethyl-omega-phenoxysäure und ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
KR960704536A (ko) 안트라사이클리논 유도체 및 유전분증에서의 이의 용도(Anthracyclinone derivatives and their use in amyloidosis)
ATE202704T1 (de) Verwendung eines natrium- oder lysiniumsalzes von crotonsäureamidderivaten zur herstellung eines arzneimittels zur behandlung von krebserkrankungen
EP0712398A1 (de) Benzopyrane und diese enthaltende pharmazeutische zusammenstellungen
DE59310044D1 (de) Imidazolylphenolderivate, diese enthaltende Arzneimittel sowie ein Verfahren zur Herstellung dieser Verbindungen und Arzneimittel
DE3887102D1 (de) Substituierte Derivate von 20,21-Dinoreburnamenin, Verfahren zur Herstellung und so hergestellte Zwischenprodukte, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammenstellungen.
DE69406451D1 (de) Verfahren zur herstellung von n-carbonylarylimine als zwischenprodukte in der synthese von therapeutisch aktiven taxol-derivaten
SE9401965D0 (sv) New compounds
ATE165599T1 (de) Benzospiroalken-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
GB2273706B (en) Fused isoxazolidine derivatives and their use in pharmaceutical compositions
HU912862D0 (en) Process for producing pharmaceutical compositions comprising substituted 2-cyclohexene derivatives
ATE281453T1 (de) 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
DE59309487D1 (de) Isoxazolcarbonsäureamide, verfahren zu ihrer herstellung und ihre verwendung
ATE181331T1 (de) Salmycine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
SE8401064L (sv) Nya isoxazoler och forfarande for framstellning derav

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee